Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06996405Not ApplicableEnrolling By Invitation

Effect of Access to Dietary Intervention in a Dialysis Unit

Role: collaborator

NCT00690586Completed

Fluid Balance, Hormones and Urine Proteomics in Nephrotic Syndrome in Childhood

Role: collaborator

NCT00999362Completed

Is T-lymphocyte Calcineurin Phosphatase Up-regulated by Treatment With Tacrolimus?

Role: collaborator

NCT00257283Phase 4Completed

Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis

Role: collaborator

All 4 trials loaded